Literature DB >> 11106553

Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.

H Behbahani1, E Popek, P Garcia, J Andersson, A L Spetz, A Landay, Z Flener, B K Patterson.   

Abstract

The role of placenta in vertical transmission is not yet fully understood. A protective role of the placenta during gestation is suggested by the finding that caesarian sections reduce the risk of transmission of human immunodeficiency virus (HIV)-1 from mother to child three- to fourfold. Here we investigated whether the immunological milieu of the placenta might be important in HIV-1 transmission. In situ imaging of immunohistochemically stained placenta sections and reverse transcriptase-polymerase chain reaction demonstrated a fourfold increase in CCR5:CXCR4 expression ratio in placentae from transmitting women compared to placentae from nontransmitting women. This chemokine receptor repertoire was consistent with an up-regulation of interleukin-4 and interleukin-10 expression in placentae from nontransmitting placentae compared to transmitting placentae. In situ imaging demonstrated that CCR5 and CXCR4 were expressed on placental macrophages and lymphocytes but not in trophoblasts. Simultaneous immunofluorescence/ultrasensitive in situ hybridization for HIV-1 gag-pol mRNA revealed that HIV-1 infects primarily CXCR4-expressing cells in placentae from nontransmitting women whereas predominantly CCR5-expressing cells were infected in placentae from transmitting women. These data are consistent with transmission of a homogeneous population of nonsyncytium-inducing HIV-1 isolates that use CCR5 as co-receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106553      PMCID: PMC1885789          DOI: 10.1016/S0002-9440(10)64819-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones.

Authors:  M P Piccinni; M G Giudizi; R Biagiotti; L Beloni; L Giannarini; S Sampognaro; P Parronchi; R Manetti; F Annunziato; C Livi
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

2.  An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta.

Authors:  N E Simister; C M Story; H L Chen; J S Hunt
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

3.  Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus.

Authors:  J S Hunt; D Vassmer; T A Ferguson; L Miller
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

4.  Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection.

Authors:  C Langston; D E Lewis; H A Hammill; E J Popek; C A Kozinetz; M W Kline; I C Hanson; W T Shearer
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

5.  Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load.

Authors:  B Weiser; S Nachman; P Tropper; K H Viscosi; R Grimson; G Baxter; G Fang; C Reyelt; N Hutcheon; H Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

7.  Anti-HIV effect of beta subunit of human chorionic gonadotropin (beta hCG) in vitro.

Authors:  A S Bourinbaiar; S Lee-Huang
Journal:  Immunol Lett       Date:  1995-01       Impact factor: 3.685

8.  Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro.

Authors:  F D Tóth; P Mosborg-Petersen; J Kiss; G Aboagye-Mathiesen; M Zdravkovic; H Hager; J Aranyosi; L Lampé; P Ebbesen
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

9.  Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.

Authors:  Y F Khouri; K McIntosh; L Cavacini; M Posner; M Pagano; R Tuomala; W A Marasco
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  L Briant; C M Wade; J Puel; A J Brown; M Guyader
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  15 in total

1.  Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers.

Authors:  Sharon Shalekoff; Glenda E Gray; Caroline T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.

Authors:  Vanessa L Naidoo; Jaclyn K Mann; Christie Noble; Emily Adland; Jonathan M Carlson; Jake Thomas; Chanson J Brumme; Christina F Thobakgale-Tshabalala; Zabrina L Brumme; Mark A Brockman; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 3.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

4.  Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro.

Authors:  Muriel Derrien; Albert Faye; Guillermina Dolcini; Gérard Chaouat; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Differential expression of RDC1/CXCR7 in the human placenta.

Authors:  Vishwas Tripathi; Romsha Verma; Amit Dinda; Neena Malhotra; Jagdeep Kaur; Kalpana Luthra
Journal:  J Clin Immunol       Date:  2008-10-28       Impact factor: 8.317

6.  Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.

Authors:  Phalguni Gupta; Kelly B Collins; Deena Ratner; Simon Watkins; Gregory J Naus; Daniel V Landers; Bruce K Patterson
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

8.  Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.

Authors:  Kumud K Singh; Michael D Hughes; Jie Chen; Kelesitse Phiri; Christine Rousseau; Louise Kuhn; Anna Coutsoudis; J Brooks Jackson; Laura A Guay; Philippa Musoke; Francis Mmiro; Richard D Semba; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

9.  Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy.

Authors:  Keith Shults; Leanne Flye-Blakemore; Bruce K Patterson; Tarek Elbeik
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

10.  Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.

Authors:  A Faye; S Pornprasert; J-Y Mary; G Dolcini; M Derrien; F Barré-Sinoussi; G Chaouat; E Menu
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.